Pictet Asset Management Holding Sa Bridge Bio Pharma, Inc. Transaction History
Pictet Asset Management Holding Sa
- $86.3 Billion
- Q1 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 2,090,268 shares of BBIO stock, worth $74.1 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,090,268
Previous 1,807,472
15.65%
Holding current value
$74.1 Million
Previous $49.6 Million
45.69%
% of portfolio
0.08%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$782 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$683 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$528 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$441 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$254 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.26B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...